Skip to main content


It's not every day you see an analyst raising his or her target price on a stock because they feel the stock deserves a higher multiple - at least, not in today's market. However, Anthony Zicha, an analyst at Scotia Capital, has done just that with Stantec Inc. , a diversified engineering firm that stands to benefit from rising stimulus spending.

The company reported earnings of 45 cents a share in the first quarter, above the consensus expectation for 43 cents a share. As a result, he believes the shares should trade at 14-times estimated 2010 earnings, up from an earlier multiple of 12-times earnings. The shares are currently trading at 11.6-times 2010 estimated earnings. He raised his target price on the shares to $32 from $28 previously.

"We believe a higher multiple is justified given: (1) the stability of Stantec's revenues, and (2) the potential boost to business in 2010 as a result of North American stimulus packages," Mr. Zicha said in a note.

Story continues below advertisement

The move comes as a number of other analysts raised their target prices on Stantec this week, while maintaining either "market perform" or "sector perform" recommendations. BMO Nesbitt Burns raised their target to $29 from $25. CIBC World Markets raised their target to $28 from $24. And Cormark Securities raised their target to $30 from $28.

Report an error
As of December 20, 2017, we have temporarily removed commenting from our articles. We hope to have this resolved by the end of January 2018. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.